{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:15:56Z","timestamp":1784344556170,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaad.2018.09.031","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T21:54:49Z","timestamp":1538430889000},"page":"957-969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review"],"prefix":"10.1016","volume":"80","author":[{"given":"George A.","family":"Zakhem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Motosko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euphemia W.","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.09.031_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.reprotox.2008.06.003","article-title":"Paternal exposure and counselling: experience of a teratology information service","volume":"26","author":"Marco De Santis ea","year":"2008","journal-title":"Reprod Toxicol"},{"issue":"11","key":"10.1016\/j.jaad.2018.09.031_bib2","first-page":"713","article-title":"The new pregnancy and lactation labeling rule","volume":"41","author":"Pernia","year":"2016","journal-title":"P T"},{"key":"10.1016\/j.jaad.2018.09.031_bib3","series-title":"Comprehensive Dermatologic Drug Therapy","article-title":"Dermatologic drugs during pregnancy and lactation","author":"Lee","year":"2013"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.031_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1439-0272.1986.tb01801.x","article-title":"The effects of\u00a0long-term colchicine therapy on male fertility in patients\u00a0with familial Mediterranean fever","volume":"18","author":"Ehrenfeld","year":"1986","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.jaad.2018.09.031_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0015-0282(16)45622-0","article-title":"Suppression of spermatogenesis in patients with Behcet's disease treated with cyclophosphamide and colchicine","volume":"36","author":"Fukutani","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaad.2018.09.031_bib6","series-title":"Colcrys (colchicine) [prescribing information]","year":"2015"},{"issue":"5934","key":"10.1016\/j.jaad.2018.09.031_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/bmj.3.5934.763","article-title":"Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis","volume":"3","author":"Currey","year":"1974","journal-title":"Br Med J"},{"issue":"7926","key":"10.1016\/j.jaad.2018.09.031_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(75)90059-8","article-title":"Return of spermatogenesis after stopping cyclophosphamide therapy","volume":"2","author":"Buchanan","year":"1975","journal-title":"Lancet"},{"issue":"7750","key":"10.1016\/j.jaad.2018.09.031_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(72)90358-3","article-title":"Sterility and testicular atrophy related to cyclophosphamide therapy","volume":"1","author":"Fairley","year":"1972","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jaad.2018.09.031_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.bmt.1703651","article-title":"Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling","volume":"30","author":"Anserini","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"6507","key":"10.1016\/j.jaad.2018.09.031_bib11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.291.6507.1457","article-title":"Long term effects of cyclophosphamide on testicular function","volume":"291","author":"Watson","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"8231","key":"10.1016\/j.jaad.2018.09.031_bib12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(81)92348-5","article-title":"Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods","volume":"1","author":"Trompeter","year":"1981","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.031_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3476(77)81305-X","article-title":"Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty","volume":"91","author":"Lentz","year":"1977","journal-title":"J Pediatr"},{"issue":"1-2","key":"10.1016\/j.jaad.2018.09.031_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1383-5718(00)00170-4","article-title":"Chromosome analysis of human spermatozoa following in\u00a0vitro exposure to cyclophosphamide, benzo(a)pyrene and N-nitrosodimethylamine in the presence of rat liver S9","volume":"491","author":"Watanabe","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.jaad.2018.09.031_bib15","series-title":"Cyclophosphamide capsules [prescribing information]","year":"2013"},{"issue":"9","key":"10.1016\/j.jaad.2018.09.031_bib16","first-page":"32","article-title":"Concentrations of doxycycline in\u00a0human seminal plasma","author":"Eliasson","year":"1976","journal-title":"Scand J Iinfect Dis Suppl"},{"key":"10.1016\/j.jaad.2018.09.031_bib17","series-title":"Doryx (doxycycline) [prescribing information]","year":"2008"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.031_bib18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/jc.2006-2203","article-title":"The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men","volume":"92","author":"Amory","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.031_bib19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(05)68270-5","article-title":"Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men","volume":"162","author":"Overstreet","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.jaad.2018.09.031_bib20","series-title":"Propecia (finasteride) [prescribing information]","year":"2014"},{"issue":"5086","key":"10.1016\/j.jaad.2018.09.031_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/214403a0","article-title":"Binding of tetracycline to mammalian spermatozoa","volume":"214","author":"Ericsson","year":"1967","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jaad.2018.09.031_bib22","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/humrep\/13.7.1878","article-title":"Effects of co-trimoxazole, erythromycin, amoxycillin, tetracycline and chloroquine on sperm function in\u00a0vitro","volume":"13","author":"Hargreaves","year":"1998","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.031_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jaad.2018.09.031_bib24","first-page":"1355","article-title":"Thalidomide is distributed into human semen after oral dosing","volume":"29","author":"Teo","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaad.2018.09.031_bib25","series-title":"Thalomid (thalidomide) [prescribing information]","year":"2017"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.031_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1439-0272.1990.tb02034.x","article-title":"Andrological investigations in men treated with acitretin (Ro 10-1670)","volume":"22","author":"Parsch","year":"1990","journal-title":"Andrologia"},{"key":"10.1016\/j.jaad.2018.09.031_bib27","series-title":"Soriatane (acitretin) [prescribing information]","year":"2017"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.031_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1439-0272.1987.tb01915.x","article-title":"Spermatological investigations in patients treated with etretinate and isotretinoin","volume":"19","author":"Torok","year":"1987","journal-title":"Andrologia"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.031_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/15569527.2015.1119839","article-title":"The effect of systemic isotretinoin on male fertility","volume":"35","author":"Cinar","year":"2016","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jaad.2018.09.031_bib30","series-title":"Claravis (isotretinoin) [prescribing information]","year":"2016"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.031_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000251036","article-title":"Studies of human semen in topical corticosteroid-treated and in methotrexate-treated psoriatics","volume":"154","author":"Grunnet","year":"1977","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2018.09.031_bib32","series-title":"Methotrexate tablets [prescribing information]","year":"2016"},{"issue":"726","key":"10.1016\/j.jaad.2018.09.031_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/pgmj.62.726.269","article-title":"Male\u00a0fertility in Crohn's disease","volume":"62","author":"Burnell","year":"1986","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaad.2018.09.031_bib34","series-title":"Deltasone (prednisone) [prescribing information]","year":"2015"},{"key":"10.1016\/j.jaad.2018.09.031_bib35","series-title":"Solu-Medrol (methylprednisolone sodium) [prescribing information]","year":"2011"},{"key":"10.1016\/j.jaad.2018.09.031_bib36","unstructured":"Decadron (dexamethasone tablets, USP) [prescribing information]. Whitehouse Station, NJ: Merck & CO., Inc."},{"key":"10.1016\/j.jaad.2018.09.031_bib37","unstructured":"Solu-Cortef (hydrocortisone sodium succinate for injection, USP) [prescribing information]. Kalamazoo, MI: Pharmacia & Upjohn."},{"key":"10.1016\/j.jaad.2018.09.031_bib38","series-title":"Comprehensive Dermatologic Drug Therapy","author":"Lee","year":"2013"},{"key":"10.1016\/j.jaad.2018.09.031_bib39","unstructured":"Targretin (bexarotene)[prescribing information]. San Diego, CA: Ligand Pharmaceuticals Incorporated."},{"key":"10.1016\/j.jaad.2018.09.031_bib40","series-title":"Solodyn(minocycline)[prescribing information]","year":"2017"},{"key":"10.1016\/j.jaad.2018.09.031_bib41","series-title":"VFEND (voriconazole) [prescribing information]","year":"2010"},{"key":"10.1016\/j.jaad.2018.09.031_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaad.2018.09.031_bib43","first-page":"73","article-title":"Effects of colchicine on spermiogenesis in the mouse","volume":"51","author":"Handel","year":"1979","journal-title":"J Embryol Exp Morphol"},{"issue":"3","key":"10.1016\/j.jaad.2018.09.031_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/HMBCI.2010.035","article-title":"Human type 3 5alpha-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride","volume":"2","author":"Yamana","year":"2010","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"2","key":"10.1016\/j.jaad.2018.09.031_bib45","first-page":"484","article-title":"Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men","volume":"75","author":"Rittmaster","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2018.09.031_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/(SICI)1097-0045(1996)6+<88::AID-PROS17>3.0.CO;2-N","article-title":"Role of dihydrotestosterone in androgen action","volume":"6","author":"Wilson","year":"1996","journal-title":"Prostate Suppl"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.031_bib47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000147852","article-title":"Immunocytochemical evidence for differential subcellular localization of 5 alpha-reductase isoenzymes in human tissues","volume":"156","author":"Aumuller","year":"1996","journal-title":"Acta Anat (Basel)"},{"issue":"5","key":"10.1016\/j.jaad.2018.09.031_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1695-4033(04)78429-5","article-title":"[Newborn with bladder extrophy associated with finasteride exposure]","volume":"61","author":"Lechuga Sancho","year":"2004","journal-title":"An Pediatr (Barc)"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.031_bib49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0015-0282(16)44057-4","article-title":"Ureaplasma urealyticum and human infertility: the effect of antibiotic therapy on semen quality","volume":"31","author":"Swenson","year":"1979","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.jaad.2018.09.031_bib50","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.urology.2011.08.062","article-title":"Empirical treatment of low-level leukocytospermia with doxycycline in male infertility patients","volume":"78","author":"Hamada","year":"2011","journal-title":"Urology"},{"issue":"7512","key":"10.1016\/j.jaad.2018.09.031_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jaad.2018.09.031_bib52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0890-6238(93)90025-3","article-title":"Assessment of the effectiveness of animal developmental toxicity testing for human safety","volume":"7","author":"Newman","year":"1993","journal-title":"Reprod Toxicol"},{"issue":"6495","key":"10.1016\/j.jaad.2018.09.031_bib53","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/bmj.291.6495.574","article-title":"Plasma testosterone concentrations in asthmatic men treated with glucocorticoids","volume":"291","author":"Reid","year":"1985","journal-title":"Br Med J (Clin Res Ed)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218326410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218326410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:52:43Z","timestamp":1759272763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218326410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0190962218326410"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.031","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}